Simon N. Whitney

TL;DR: A model of medical decision making was used to build a model of informed consent, which was then used to analyze the difference between informed consent and shared decision making, and it is hoped that this analysis will provide clinicians with helpful insights.

TL;DR: This article proposes a model of medical decisions based on 2 fundamental characteristics of each decision—importance and certainty and shows how one class of decisions lends itself particularly well to shared decision making.

TL;DR: Simulation suggest that restricting randomized trials to patients expressing drug target, instead of using unselected patient populations, could substantially reduce patient numbers required to demonstrate efficacy, and the marked imbalance between potential life-years lost versus saved renders the regulatory burden potentially unethical.

TL;DR: A new model of decision making is presented that explains why clinicians sometimes justifiably assume decisional priority when there is one best medical choice and suggests that clinicians should particularly encourage parents (and children, when appropriate) to assumption decisionalpriority when there are two or more clinically reasonable choices.

TL;DR: The authors extend the model of medical decision making beyond shared decisions in 2 dimensions and incorporate a class of medical decisions in which there is only one medically reasonable treatment option, such as the removal of a primary melanoma.